- Zacks
Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
- Zacks
Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
- Zacks
GE Healthcare's (GEHC) Revolution RT to Aid Cancer Treatment
GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.
